SCHEMBL24589989

SCHEMBL24589989

CCN(CC)c1ccc2c(C)c(CCC(=O)NCCc3ccc(F)cc3)c(=O)oc2c1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.64
▸ MAPT P10636 8/20 0.62
▸ THRB P10828 2/20 0.59
▸ KDM4E B2RXH2 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ GLA P06280 2/20 0.57
▸ ATM Q13315 2/20 0.57
▸ GAA P10253 2/20 0.57
▸ KLK7 P49862 1/20 0.57
▸ IGLV6-57 P01721 4/20 0.57
▸ POLB P06746 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ CASP1 P29466 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ CASP7 P55210 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ SRC P12931 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24590344 0.95 TP53 (0.61) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL22501693 0.92 MAPT (0.74) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL24589802 0.90 MAPT (0.61) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL24589618 0.90 IGLV6-57 (0.62) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL22501767 0.88 MAPT (0.68) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL22501768 0.86 IGLV6-57 (0.60) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL24589805 0.86 MAPT (0.66) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL24590314 0.86 KDM4E (0.60) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL24589881 0.85 MAPT (0.77) TP53MAPTTHRBKDM4EALDH1A1
SCHEMBL24589803 0.85 IGLV6-57 (0.78) TP53MAPTTHRBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 TP53 553/4885MAPT 41/4885THRB 4076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback